Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P F Spano

Showing results (201-210 of 210) with videos related to

Pageof 21
Sort By:
You have reached the last page of results.This site can display upto 210 results.
Life Sciences|March 10, 1995
Different neurotransmitter systems are involved in the development of esophageal achalasiaS Sigala, G Missale, C Missale, et al.
Advances in Biochemical Psychopharmacology|January 1, 1977
Evidence for the existence of regulatory DA receptors in the substantia nigraG Di Chiara, G P Mereu, L Vargiu, et al.
Journal of Neurochemistry|January 1, 1977
Changes in specific activity of dopamine metabolites as evidence of a multiple compartmentation of dopamine in striatal neuronsA Groppetti, S Algeri, F Cattabeni, et al.
Substance and Alcohol Actions/Misuse|January 1, 1984
Chronic ethanol treatment changes the number of beta-receptors in rat brain microvesselsL Lucchi, A Cazzaniga, G B Picotti, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|February 25, 2016
The miR-21/PTEN/Akt signaling pathway is involved in the anti-tumoral effects of zoledronic acid in human breast cancer cell linesM Fragni, S A Bonini, P Bettinsoli, et al.
Journal of Clinical Laboratory Analysis|January 1, 1989
Properties of benzodiazepine binding sites in peripheral blood lymphocytesL Garau, M Memo, M Pizzi, et al.
Dementia and Geriatric Cognitive Disorders|March 15, 2002
Effects of rivastigmine on cognitive function in dementia with lewy bodies: a randomised placebo-controlled international study using the cognitive drug research computerised assessment systemK A Wesnes, I G McKeith, R Ferrara, et al.
Neuropharmacology|October 26, 1999
Group-I metabotropic glutamate receptors: hypotheses to explain their dual role in neurotoxicity and neuroprotectionF Nicoletti, V Bruno, M V Catania, et al.
Cell Death and Differentiation|April 9, 2005
NF-kappaB factor c-Rel mediates neuroprotection elicited by mGlu5 receptor agonists against amyloid beta-peptide toxicityM Pizzi, I Sarnico, F Boroni, et al.
Neuroscience|December 3, 2014
CHF5074 (CSP-1103) induces microglia alternative activation in plaque-free Tg2576 mice and primary glial cultures exposed to beta-amyloidV Porrini, A Lanzillotta, C Branca, et al.
Pageof 21

Showing results (201-210 of 210) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 210 results.
Life Sciences|March 10, 1995
Different neurotransmitter systems are involved in the development of esophageal achalasiaS Sigala, G Missale, C Missale, et al.
Advances in Biochemical Psychopharmacology|January 1, 1977
Evidence for the existence of regulatory DA receptors in the substantia nigraG Di Chiara, G P Mereu, L Vargiu, et al.
Journal of Neurochemistry|January 1, 1977
Changes in specific activity of dopamine metabolites as evidence of a multiple compartmentation of dopamine in striatal neuronsA Groppetti, S Algeri, F Cattabeni, et al.
Substance and Alcohol Actions/Misuse|January 1, 1984
Chronic ethanol treatment changes the number of beta-receptors in rat brain microvesselsL Lucchi, A Cazzaniga, G B Picotti, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|February 25, 2016
The miR-21/PTEN/Akt signaling pathway is involved in the anti-tumoral effects of zoledronic acid in human breast cancer cell linesM Fragni, S A Bonini, P Bettinsoli, et al.
Journal of Clinical Laboratory Analysis|January 1, 1989
Properties of benzodiazepine binding sites in peripheral blood lymphocytesL Garau, M Memo, M Pizzi, et al.
Dementia and Geriatric Cognitive Disorders|March 15, 2002
Effects of rivastigmine on cognitive function in dementia with lewy bodies: a randomised placebo-controlled international study using the cognitive drug research computerised assessment systemK A Wesnes, I G McKeith, R Ferrara, et al.
Neuropharmacology|October 26, 1999
Group-I metabotropic glutamate receptors: hypotheses to explain their dual role in neurotoxicity and neuroprotectionF Nicoletti, V Bruno, M V Catania, et al.
Cell Death and Differentiation|April 9, 2005
NF-kappaB factor c-Rel mediates neuroprotection elicited by mGlu5 receptor agonists against amyloid beta-peptide toxicityM Pizzi, I Sarnico, F Boroni, et al.
Neuroscience|December 3, 2014
CHF5074 (CSP-1103) induces microglia alternative activation in plaque-free Tg2576 mice and primary glial cultures exposed to beta-amyloidV Porrini, A Lanzillotta, C Branca, et al.
Pageof 21